Adriana Buskin,Lili Zhu,Valeria Chichagova,Basudha Basu,Sina Mozaffari-Jovin,David Dolan,Alastair Droop,Joseph Collin,Revital Bronstein,Sudeep Mehrotra,Michael Farkas,Gerrit Hilgen,Kathryn White,Dean Hallam,Katarzyna Bialas,Git Chung,Carla Mellough,Yuchun Ding,Natalio Krasnogor,Stefan Przyborski,Jumana Al-Aama,Sameer Alharthi,Yaobo Xu,Gabrielle Wheway,Katarzyna Szymanska,Martin McKibbin,Chris F Inglehearn,David J Elliott,Susan Lindsay,Robin R Ali,David H Steel,Lyle Armstrong,Evelyne Sernagor,Eric Pierce,Reinhard Lüehrmann,Sushma-Nagaraja Grellscheid,Colin A Johnson,Majlinda Lako

Abstract:Summary Mutations in pre-mRNA processing factors (PRPFs) cause 40% of autosomal dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed PRPFs cause retinal disease. To understand the molecular basis of this phenotype, we have generated RP type 11 (PRPF31- mutated) patient-specific retinal organoids and retinal pigment epithelium (RPE) from induced pluripotent stem cells (iPSC). Impaired alternative splicing of genes encoding pre-mRNA splicing proteins occurred in patient-specific retinal cells and Prpf31 +/− mouse retinae, but not fibroblasts and iPSCs, providing mechanistic insights into retinal-specific phenotypes of PRPFs. RPE was the most affected, characterised by loss of apical-basal polarity, reduced trans-epithelial resistance, phagocytic capacity, microvilli, and cilia length and incidence. Disrupted cilia morphology was observed in patient-derived-photoreceptors that displayed progressive features associated with degeneration and cell stress. In situ gene-editing of a pathogenic mutation rescued key structural and functional phenotypes in RPE and photoreceptors, providing proof-of-concept for future therapeutic strategies. eTOC PRPF31 is a ubiquitously expressed pre-mRNA processing factor that when mutated causes autosomal dominant RP. Using a patient-specific iPSC approach, Buskin and Zhu et al. show that retinal-specific defects result from altered splicing of genes involved in the splicing process itself, leading to impaired splicing, loss of RPE polarity and diminished phagocytic ability as well as reduced cilia incidence and length in both photoreceptors and RPE. Highlights Successful generation of iPSC-derived RPE and photoreceptors from four RP type 11 patients RPE cells express the mutant PRPF31 protein and show the lowest expression of wildtype protein PRPF31 mutations result in altered splicing of genes involved in pre-mRNA splicing in RPE and retinal organoids Prpf31 haploinsufficiency results in altered splicing of genes involved in pre-mRNA splicing in mouse retina RPE cells display loss of polarity, reduced barrier function and phagocytosis Photoreceptors display shorter and fewer cilia and degenerative features RPE cells display most abnormalities suggesting they might be the primary site of pathogenesis In situ gene editing corrects the mutation and rescues key phenotypes

Modeling autosomal dominant retinitis pigmentosa by using patient-specific retinal organoids with a class-3 RHO mutation

Modeling Autosomal Dominant Optic Atrophy Using Induced Pluripotent Stem Cells and Identifying Potential Therapeutic Targets.

Disease modeling and pharmacological rescue of autosomal dominant retinitis pigmentosa associated with RHO copy number variation

Abnormal morphology and function in retinal ganglion cells derived from patients-specific iPSCs generated from individuals with Leber's hereditary optic neuropathy.

Retinal Organoid Models Show Heterozygous Rhodopsin Mutation Favors Endoplasmic Reticulum Stress-Induced Apoptosis in Rods

Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation

Human retinal organoids harboring IMPG2 mutations exhibit a photoreceptor outer segment phenotype that models advanced retinitis pigmentosa

Knockout and replacement gene surgery to treat rhodopsin-mediated autosomal dominant retinitis pigmentosa.

Rhodopsin-associated retinal dystrophy: Disease mechanisms and therapeutic strategies

Modeling PRPF31 retinitis pigmentosa using retinal pigment epithelium and organoids combined with gene augmentation rescue

Compensation of inner retina to early-stage photoreceptor degeneration in a RhoP23H/+ mouse model of retinitis pigmentosa

Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice

A Focus on Human iPSC-Derived Organoid Models

Early Developmental Characteristics and Features of a Three-Dimensional Retinal Organoid Model of X-Linked Juvenile Retinoschisis

Protective effects of human iPS-derived retinal pigmented epithelial cells on retinal degenerative disease

Molecular pathology of Usher 1B patient-derived retinal organoids at single cell resolution

Inducible Pluripotent Stem Cells to Model and Treat Inherited Degenerative Diseases of the Outer Retina: 3D-Organoids Limitations and Bioengineering Solutions

CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model

Human iPSC-derived RPE and retinal organoids reveal impaired alternative splicing of genes involved in pre-mRNA splicing in PRPF31 autosomal dominant retinitis pigmentosa

Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies

Generation of nonhuman primate retinitis pigmentosa model by in situ knockout of RHO in rhesus macaque retina